Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.


Journal

Targeted oncology
ISSN: 1776-260X
Titre abrégé: Target Oncol
Pays: France
ID NLM: 101270595

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 29 10 2020
medline: 29 10 2020
entrez: 28 10 2020
Statut: ppublish

Résumé

An Online First version of this article was made available online at https://link.springer.com/article/10.1007/s11523-020-00757-3 on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted.

Identifiants

pubmed: 33113041
doi: 10.1007/s11523-020-00765-3
pii: 10.1007/s11523-020-00765-3
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

809-810

Commentaires et corrections

Type : ErratumFor

Auteurs

Giulia Orsi (G)

Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Via del Pozzo 71, Modena, Italy.

Francesco Tovoli (F)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.

Vincenzo Dadduzio (V)

Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.

Caterina Vivaldi (C)

Division of Medical Oncology 2, Pisa University Hospital, Pisa, Italy.
Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Via Savi 6, 56126, Pisa, Italy.

Oronzo Brunetti (O)

Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Luca Ielasi (L)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.

Fabio Conti (F)

Department of Internal Medicine, Faenza Hospital, AUSL Romagna, Faenza, Italy.

Giulia Rovesti (G)

Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Via del Pozzo 71, Modena, Italy.

Laura Gramantieri (L)

Center for Applied Biomedical Research (CRBa), St. Orsola-Malpighi University Hospital, Bologna, Italy.

Mario Domenico Rizzato (MD)

Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.

Irene Pecora (I)

Division of Medical Oncology 2, Pisa University Hospital, Pisa, Italy.

Antonella Argentiero (A)

Medical Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Federica Teglia (F)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.

Sara Lonardi (S)

Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.

Francesca Salani (F)

Division of Medical Oncology 2, Pisa University Hospital, Pisa, Italy.

Alessandro Granito (A)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.

Vittorina Zagonel (V)

Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.

Giorgia Marisi (G)

Biosciences Laboratory, Istituto Scientifco Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy.

Giuseppe Cabibbo (G)

Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy.

Francesco Giuseppe Foschi (FG)

Department of Internal Medicine, Faenza Hospital, AUSL Romagna, Faenza, Italy.

Francesca Benevento (F)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.

Alessandro Cucchetti (A)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.

Fabio Piscaglia (F)

Department of Medical and Surgical Sciences-DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.

Stefano Cascinu (S)

Vita-Salute San Rafaele University, Milan, Italy.
Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy.

Mario Scartozzi (M)

Department of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.

Andrea Casadei-Gardini (A)

Vita-Salute San Rafaele University, Milan, Italy. casadeigardini@gmail.com.
Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy. casadeigardini@gmail.com.

Classifications MeSH